NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include active license agreements, topical medicinal cannabis lotions, and a proprietary microbial fuel cell technology, today announced that corporate presentations are scheduled at five distinct investment conferences from April 01 through June 30, 2014. These five corporate presentations are booked in: Berlin, Las Vegas, New York City, and Philadelphia . Most of these events will be webcast or video recorded; webcast details will be distributed as soon as they are available.
With its acquisition of Pilus Energy LLC ("Pilus Energy") complete and its recently executed definitive merger agreement with Honeywood LLC ("Honeywood"), the Company has made a strategic decision to aggressively market itself to the global investment community. The Company believes that its diversified portfolio of life sciences businesses represents a compelling value investment opportunity for both individual and institutional investors.
1) April 08-09, 2014 (BERLIN, GERMANY)
World Resource Ventures European Spring Conference , Location: The Representative Office of Bremin in Berlin (Hiroshimastrasse 22-26), Berlin, Germany.
Company Presenter(s): To Be Determined
( http://www.worldresourceventures.com/berlin-a...v-nrw.html )
2) April 29-May 01, 2014 (LAS VEGAS, NEVADA)
Growth Capital Expo 2014 , Location: Caesar's Palace Hotel (3570 S. Las Vegas Blvd.), Las Vegas, Nevada
Company Presenter(s): Dr. Stella M. Sung, Chief Executive Officer, Tauriga Sciences Inc.
( http://www.growthcapitalexpo.com/growth-capit...las-vegas/ )
3) May 28-29, 2014 (PHILADELPHIA, PENNSYLVANIA)
WaterVent Conference North America , Location: Woodcock Washburn LLP (2929 Arch St.), Philadelphia, Pennsylvania
Company Presenter(s): Seth M. Shaw, Vice President - Strategic Planning and David Schweizer, Vice President -NuclearBot Development, Tauriga Sciences, Inc.
( http://www.watervent.com/overview-philadelphia-2014.html )
4) May 29, 2014 (NEW YORK, NY)
Marcum Microcap Conference , Location: Grand Hyatt New York (109 E. 42nd Street), New York, NY
Company Presenter(s): Dr. Stella M. Sung, Chief Executive Officer, Tauriga Sciences Inc.
( http://www.marcumllp.com/microcap )
5) June 19, 2014 (NEW YORK, NY)
25th Annual WSAF Institutional Investor Conference , Location: The University Club (1 W. 54th Street), New York, NY
Company Presenter(s): Dr. Stella M. Sung, Chief Executive Officer, Tauriga Sciences Inc.
( http://www.analyst-conference.com )
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), the developer of proprietary synthetic biology powered microbial fuel cell technology that creates electricity while consuming polluting molecules from wastewater. The Company's corporate websites can be found at ( www.tauriga.com ) and ( www.pilusenergy.com ).
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Tauriga Sciences, Inc.: Dr. Stella M. Sung Chairman and Chief Executive Officer Tauriga Sciences, Inc. www.tauriga.com San Diego: + 1-858-353-5749 Montreal: + 1-514-840-3697 Email:
